PAPER Jay GW, Demattos RB, Weinstein EJ, Philbert MA, Pardo ID, Brown TP
SEARCH RESULTS
330029 RESULTS
PAPER Coppedè F
One-carbon metabolism and Alzheimer's disease: focus on epigenetics.
Curr Genomics. 2010 Jun;11(4):246-60. PubMed: 21119889PAPER Lee JH, Gonzalez GH
Towards integrative gene prioritization in Alzheimer's disease.
Pac Symp Biocomput. 2011;:4-13. PubMed: 21121028PAPER Sorani MD, Manley GT, Claude Hemphill J, Baranzini SE
Dynamic, multi-level network models of clinical trials.
Pac Symp Biocomput. 2011;:38-49. PubMed: 21121031PAPER Chen HK, Ji ZS, Dodson SE, Miranda RD, Rosenblum CI, Reynolds IJ, Freedman SB, Weisgraber KH, Huang Y, Mahley RW
Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease.
J Biol Chem. 2011 Feb 18;286(7):5215-21. PubMed: 21118811PAPER Uemura K, Farner KC, Hashimoto T, Nasser-Ghodsi N, Wolfe MS, Koo EH, Hyman BT, Berezovska O
Substrate docking to γ-secretase allows access of γ-secretase modulators to an allosteric site.
Nat Commun. 2010;1:130. PubMed: 21119643PAPER Akdogan I, Kiroglu Y, Onur S, Karabuluti N
The volume fraction of brain ventricles to total brain volume: a computed tomography stereological study.
Folia Morphol (Warsz). 2010 Nov;69(4):193-200. PubMed: 21120804PAPER Lenzken SC, Romeo V, Zolezzi F, Cordero F, Lamorte G, Bonanno D, Biancolini D, Cozzolino M, Pesaresi MG, Maracchioni A, Sanges R, Achsel T, Carrì MT, Calogero RA, Barabino SM
Mutant SOD1 and mitochondrial damage alter expression and splicing of genes controlling neuritogenesis in models of neurodegeneration.
Hum Mutat. 2011 Feb;32(2):168-82. PubMed: 21120952GLUT4, C-terminus
ANTIBODY polyclonal manufacturer Cat# 07-1404<br />Reference: <br /><a href="/papers/days-criterion-indicator-toxicity-associated-human-alzheimer-amyloid-beta-oligomers" target="_new">Gandy, 2010</a> immunogen = syntheti
Gillian Black-Noller
PfizerUnited States
Danielle Simmons
Stanford UniversityUnited States